Diseases, Conditions, Syndromes

Scientists raise alarm over signs of vaccine 'hesitancy'

Scientists called for urgent action to improve public trust in immunisation as research suggested sizeable minorities in some nations may be reluctant to be vaccinated against COVID-19.

Diseases, Conditions, Syndromes

COVID-19: German scientists lay basis for a passive vaccination

Researchers at the German Center for Neurodegenerative Diseases (DZNE) and Charité - Universitätsmedizin Berlin have identified highly effective antibodies against the coronavirus SARS-CoV-2 and are now pursuing the development ...

Oncology & Cancer

Cervical cancer vaccine shows promise

A vaccine against cervical cancer, being developed by Inovio Pharmaceuticals Inc. of Blue Bell, Pa., produced positive results in a small sample of 18 women.

HIV & AIDS

Study explores barriers to HIV vaccine response

Researchers at The Scripps Research Institute (TSRI) discovered that an antibody that binds and neutralizes HIV likely also targets the body's own "self" proteins. This finding could complicate the development of HIV vaccines ...

Parkinson's & Movement disorders

EU team launches clinical trial of Parkinson's vaccine

Today the EU-consortium SYMPATH starts recruitment for a Phase I study of a Parkinson's vaccine candidate called AFFITOPE PD03A. This vaccine is one out of a designated pool of promising vaccine candidates based on AFFiRiS' ...

Diseases, Conditions, Syndromes

Evidence for reduced antibody protection against SARS-CoV-2 variants

Testing and vaccination—these are the pillars on which humanity is trying to get a grip on the Coronavirus pandemic. Although it is taking longer than many had expected, it is believed that it is only a matter of time before ...

page 12 from 35